FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to psychiatry and drug addiction, and may be used for detoxification-infusion therapy of the patients used psychotropic cannabis products. That is ensured by the infusion intravenous drop-by-drop sequential administration of drugs. A mixture containing 5% glucose 200 ml, 25% magnesium sulphate 10 ml and 4% potassium chloride 10 ml are administered. That is combined with the additional bolus administration of 5% vitamin B1 2 ml. That...

According to the invention, zerumbone is used for a slimming topical treatment. Zerumbone is preferably extracted from Zingiber zerumbet (L.) Smith.In addition according to the invention zerumbone can be combined with an agent that mimics the beneficial effects of caloric restriction via a hormetic response, preferably a Globularia cordifolia extract,and/or a lipolytic additional active agent, preferably from the methylxanthine family, including caffeine, theophylline, theobromine or aminophylli...

FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to ophthalmology, endocrinology and restorative medicine, and may be used to treat the patients with non-proliferative diabetic retinopathy. For this purpose, with underlying background individual antidiabetic therapy, endonasal electrophoresis with 0.1% Semax in a daily dose of 700 mcg is applied in a patient lying on his/her back. A bifurcated positive electrode is coated with cotton swabs each of which is moistened with 7 drops o...

Pharmaceutical composition comprises enoximone, which is administered intravenously in an amount of not > 300 mg per day, preferably 200 mg per day. An independent claim is also included for a kit comprising the pharmaceutical composition and a drug including beta -2 sympathomimetic agent, catecholamines, aminophylline, corticosteroids, parasympatholytic agent, magnesium sulfate, ketamine and/or S-ketamine for treating status asthmaticus. ACTIVITY : Antiasthmatic. Test details are described but ...

Disclosed is animmediate release-sustained release osmotic pump tablet comprising methoxyphenamine or its hydrochloride, noscapine, aminophylline, chlorphenamine maleate. The tablet comprises two drug-release parts,andone is immediate release part comprising 1-70% of active ingredient coated on the surface of the osmotic pump tablet,whichmake drugs immediately release when the tablet gets into the stomach

Quick release-sustained release composition containing methoxyphenamine or hydrochloride thereof, narcotine, aminophylline and chlorphenamine maleate is disclosed by the present invention. The quick release part has 1-70% effective components and the sustained release part has 30-99% effective components,and the release time is 8-24 hours. The preparations of the quick release-sustained composition includes a quick release-sustained release tablet, a quick release-sustained release capsule or a ...